- Zacks
Penumbra (PEN) Q1 Earnings Lag Estimates, Margins Expand
Penumbra's (PEN) Thrombectomy product category shows encouraging growth trends, reflecting strong momentum in CAVT products.
- Zacks
Penumbra's (PEN) New Launch to Enhance Blood Clot Removal
Penumbra's (PEN) latest offering is likely to enable physicians to restore blood flow more quickly and further minimize blood loss.
- Zacks
Here's Why You Should Retain Penumbra (PEN) Stock for Now
Investors are optimistic about Penumbra (PEN) on strength exhibited in the Thrombectomy business and global expansion.
